Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: Results of the COBALT (Comparison of Bare-Metal Stents in All-Comers' Lesion Treatment) registry

Journal of Interventional Cardiology

Volumn 24, Issue 6, 2011, Pages 496-504

  Abdel Wahab, Mohamed ^a   Toelg, Ralph ^a   Kassner, Guido ^a   Klatt, Lothar ^a   Sherif, Mohammad A ^a   Geist, Volker ^a   Richardt, Gert ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; COBALT;

ADULT; AGED; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; CHROMIUM; COBALT; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; REGISTRIES; STATISTICS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 83955165902     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00672.x     Document Type: Article

References (19)

1. Windecker S, Simon R, Lins M, et al,. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: The TiNOX trial. Circulation 2005; 111: 2617-2622. (Pubitemid 40740861)
2. Dahm JB, Willems T, Wolpers HG, et al,. Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent restenosis rates: Results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation). EuroIntervention 2009; 4: 502-508.
3. Tamburino C, La Manna A, Di Salvo ME, et al,. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: The ATLANTA (Assessment of The Latest NonThrombogenic Angioplasty stent) trial. JACC Cardiovasc Interv 2009; 2: 197-204.
4. Kornowski R, Vaknin-Assa H, Ukabi S, et al,. PRO-Kinetic: Results from an "all-comers" single centre clinical experience. EuroIntervention 2009; 5: 109-114.
5. Moses JW, Leon MB, Popma JJ, et al,. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. (Pubitemid 37186209)
6. Stone GW, Ellis SG, Cox DA, et al,. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
7. Serruys PW, Daemen J, Morice MC, et al,. Three-year follow-up of the ARTS-II: Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention 2008; 3: 450-459.
8. Buszman P, Trznadel S, Zurakowski A, et al,. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions. Kardiol Pol 2007; 65: 1041-1046. (Pubitemid 350096909)
9. Van Oeveren W,. Reduced deposition of blood formed elements and fibrin onto amorphous silicon carbide coated stainless steel. Prog Biomed Res 1999; 2: 78-83.
10. Cutlip DE, Windecker S, Mehran R, et al,. Academic Research Consortium. Clinical end points in coronary stent trials: A case for standard definitions. Circulation 2007; 115: 2344-2351. (Pubitemid 46685903)
11. Nef HM, Möllmann H, Weber M, et al,. Cobalt-chrome MULTI-LINK VISION-stent implantation in diabetics and complex lesions: Results from the DaVinci-Registry. Clin Res Cardiol 2009; 98: 731-737.
12. Stettler C, Wandel S, Allemann S, et al,. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007; 370: 937-948. (Pubitemid 47393576)
13. Cutlip DE, Chauhan MS, Baim DS, et al,. Clinical restenosis after coronary stenting: Perspectives from multicenter clinical trials. J Am Coll Cardiol 2002; 40: 2082-2089. (Pubitemid 36005891)
14. Cutlip DE, Baim DS, Ho KK, et al,. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971. (Pubitemid 32322224)
15. Kastrati A, Mehilli J, Dirschinger J, et al,. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISARSTEREO) trial. Circulation 2001; 103: 2816-2821. (Pubitemid 32550070)
16. Pache J, Kastrati A, Mehilli J, et al,. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISARSTEREO- 2) trial. J Am Coll Cardiol 2003; 41: 1289-1292.
17. Nienaber CA, Akin I, Schneider S, et al,. for the DES.DE Study Group. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the First Phase of the Prospective Multicenter German DES.DE Registry). Am J Cardiol 2009; 104: 1362-1369.
18. Pache J, Dibra A, Mehilli J, et al,. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: A prospective, randomized trial. Eur Heart J 2005; 26: 1262-1268. (Pubitemid 41435455)
19. Brilakis ES, Lichtenwalter C, de Lemos JA, et al,. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions: The SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol 2009; 53: 919-928.